Aspira Pathlab & Diagnostics Ltd Screener
Small Cap
With a marketcap of ₹ 61.57 Cr Stock is ranked 3454
Aspira Pathlab Investment Return
Short Term
8.70 %
42.19 %
94.09 %
86.36 %
Long Term
57.01 %
-41.81 %
56.19 %
322.76 %
Aspira Pathlab Return Calculator
₹
Aspira Pathlab Revenue and Profit and Growth
- No Strength found.
- No Weakness found.